146 related articles for article (PubMed ID: 28028303)
1. Dismal outcome of therapy-related myeloid neoplasm associated with complex aberrant karyotypes and monosomal karyotype: a case report.
Tang YL; Chia WK; Yap EC; Julia MI; Leong CF; Salwati S; Wong CL
Malays J Pathol; 2016 Dec; 38(3):315-319. PubMed ID: 28028303
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
[TBL] [Abstract][Full Text] [Related]
3. Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
Snijder S; Mellink CH; van der Lelie H
Cancer Genet Cytogenet; 2008 Jan; 180(2):149-52. PubMed ID: 18206542
[TBL] [Abstract][Full Text] [Related]
4. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
[TBL] [Abstract][Full Text] [Related]
5. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
[TBL] [Abstract][Full Text] [Related]
6. Two cases of isolated symptomatic myocarditis induced by all-trans retinoic acid (ATRA).
Klein SK; Biemond BJ; van Oers MH
Ann Hematol; 2007 Dec; 86(12):917-8. PubMed ID: 17619879
[No Abstract] [Full Text] [Related]
7. Myelodysplastic syndrome following successful therapy of acute promyelocytic leukemia.
Bseiso AW; Kantarjian H; Estey E
Leukemia; 1997 Jan; 11(1):168-9. PubMed ID: 9001434
[TBL] [Abstract][Full Text] [Related]
8. Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia.
Todisco E; Testi AM; Avvisati G; Moleti ML; Cedrone M; Cimino G; Mancini F; Amadori S; Mandelli F
Leukemia; 1995 Sep; 9(9):1583-5. PubMed ID: 7658728
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?
Parajuli R; Altman J; Kuzel T; Perdekamp M; Tallman M
Am J Hematol; 2010 Oct; 85(10):829. PubMed ID: 20721888
[No Abstract] [Full Text] [Related]
10. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
Ortega JJ; Madero L; Martín G; Verdeguer A; García P; Parody R; Fuster J; Molines A; Novo A; Debén G; Rodríguez A; Conde E; de la Serna J; Allegue MJ; Capote FJ; González JD; Bolufer P; González M; Sanz MA;
J Clin Oncol; 2005 Oct; 23(30):7632-40. PubMed ID: 16234524
[TBL] [Abstract][Full Text] [Related]
11. Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapy.
Montesinos P; González JD; González J; Rayón C; de Lisa E; Amigo ML; Ossenkoppele GJ; Peñarrubia MJ; Pérez-Encinas M; Bergua J; Debén G; Sayas MJ; de la Serna J; Ribera JM; Bueno J; Milone G; Rivas C; Brunet S; Löwenberg B; Sanz M
J Clin Oncol; 2010 Aug; 28(24):3872-9. PubMed ID: 20625122
[TBL] [Abstract][Full Text] [Related]
12. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
13. Conventional induction and post-remission therapy in APL: have we arrived?
Sanz MA; Iacoboni G; Montesinos P
Best Pract Res Clin Haematol; 2014 Mar; 27(1):33-8. PubMed ID: 24907015
[TBL] [Abstract][Full Text] [Related]
14. Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age.
Finsinger P; Breccia M; Minotti C; Carmosino I; Girmenia C; Chisini M; Volpicelli P; Vozella F; Romano A; Montagna C; Colafigli G; Cimino G; Avvisati G; Petti MC; Lo-Coco F; Foà R; Latagliata R
Ann Hematol; 2015 Feb; 94(2):195-200. PubMed ID: 25186786
[TBL] [Abstract][Full Text] [Related]
15. Management of acute promyelocytic leukemia relapse in the ATRA era.
Castagnola C; Lunghi M; Corso A; Tajana M; Zappasodi P; Dabusti M; Lazzarino M; Bernasconi C
Haematologica; 1998 Aug; 83(8):714-7. PubMed ID: 9793255
[TBL] [Abstract][Full Text] [Related]
16. Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine.
Estey E; Thall PF; Pierce S; Kantarjian H; Keating M
J Clin Oncol; 1997 Feb; 15(2):483-90. PubMed ID: 9053469
[TBL] [Abstract][Full Text] [Related]
17. A case of ATRA-induced isolated myocarditis in the absence of circulating malignant cells: demonstration of the t(15;17) translocation in the inflammatory infiltrate by in situ hybridisation.
van Rijssel RH; Wegman J; Oud ME; Pals ST; van Oers MH
Leuk Res; 2010 Jul; 34(7):e142-4. PubMed ID: 20060166
[No Abstract] [Full Text] [Related]
18. Clinical features and treatment outcomes of pediatric acute promyelocytic leukemia in a Mexican pediatric hospital.
Dorantes-Acosta E; Medina-Sanson A; Jaimes-García Y; López-Martínez B
Rev Invest Clin; 2013; 65(5):392-8. PubMed ID: 24687338
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia.
Lou Y; Qian W; Meng H; Mai W; Tong H; Tong Y; Huang J; Jin J
Hematol Oncol; 2014 Mar; 32(1):40-6. PubMed ID: 23963734
[TBL] [Abstract][Full Text] [Related]
20. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
Al Bahar S; Pandita R; Bavishi K; Kreze O
Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
